10'000 Hours/DigitalVision via Getty Images Investment Overview I last covered the Swiss pharma giant Roche (OTCQX:RHHBY) in a note for Seeking Alpha in mid-May, giving the company's stock a "Buy" recommendation. Shares have risen in value by ~22% since, trading at ~$40 at the time of writing, which translates to a market cap valuation of $254bn. In that note I wrote: Roche has been struggling for top and bottom line growth over the past several years, and this may have affected its share price and valuatio ...